The discovery of igf2 imprinting in mice, described by Chiara et al. in mice and later humans (reviewed in Reference [61]), began a new era in the way researchers look at IGF2 and its participation in carcinogenesis (including CRC). The gene discussed is IGF2; the disease is colorectal carcinoma.